| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Genealogy giant Ancestry is getting into the business of healthcare. On Tuesday, the company announced two health products: AncestryHealth Core and AncestryHealth Plus, which can help users of the company's DNA test get a sense of their family health history. AncestryHealth Core will cost $149 — or $49 if users have already taken an Ancestry test — while Plus will cost $199, and additional quarterly updates after the first six months will cost $49 fee every six months. Here's what's included in the reports. Visit Business Insider's homepage for more stories. For the first time, family-history website Ancestry will tell you about your genetic health.[CR-LF][CR-LF]Users who have already submitted their spit to Ancestry before don't have to submit a new samples. The products will take about 6-8 weeks to report after ordering, even for those who have already taken the Ancestry test. The company said it plans to have the Plus program available widely in 2020. To perform the next-generation sequencing test, Ancestry's partnering with lab-testing firm Quest Diagnostics.
More than half of the US.. states and roughly one-third of major U.S. industries saw their rates of workforce drug test positives climb over the past three years – with positives hitting their highest rates in 2018 in more than a decade, according to a series of recent reports from Quest Diagnostics.[CR-LF][CR-LF]Oregon, Maine, Vermont, Alabama, Louisiana and Massachusetts had the highest rates of positive results for urine-based drug tests, according to Quest's analysis of more than 10 million screenings for illicit substances. Across the country, 4.4% of the analyzed drug tests yielded positive results in 2018. In Oregon and Maine, however, more than 6% of the tests were positive last year.
Since 1988, federal regulations have required commercial drivers to submit urine samples for pre-employment, random, and post-accident testing for prohibited drugs.[CR-LF][CR-LF]Twenty years on, the Government Accountability Office (the investigative arm of Congress) published a study outlining serious challenges confronting the Federal Motor Carrier Safety Administration in its oversight of the drug-testing program:[CR-LF][CR-LF]In more than 9% of compliance reviews conducted between 2001 and 2007, carriers had no drug-testing programs at all.Quest Diagnostics reported earlier this year a rise in urine specimens reported as invalid suggest more efforts to cheat.[CR-LF][CR-LF]Drug-testing labs are getting more sophisticated about catching cheaters, but at the same time cheaters are getting smarter about how they try to game the system.
Historically low unemployment rates and increasing marijuana use has led some employers in states where recreational cannabis is legal to drop their zero-tolerance policies.[CR-LF][CR-LF]But not everyone is ready to make the leap.[CR-LF][CR-LF]As Illinois readies for recreational marijuana to become legal on Jan. 1, employers here are being told to consider how a zero-tolerance policy may affect their ability to recruit workers.[CR-LF][CR-LF]“Unemployment is so low that employers cannot insist on a zero-tolerance policy,” said Curtis Graves, staff attorney for the Denver-based Employers Council not-for-profit. The council has surveyed Colorado employers every other year since 2014 when recreational use of cannabis was legalized in the state.[CR-LF]Marijuana positivity increased by 75% from 2013 to 2016 in the general U.S. workforce, according to the Quest Diagnostics Drug Testing Index. Nearly 9% tested positive in 2016, according to Quest.
Q&A with David Freeman. Most people I talk to in pharma and biotech know that Quest Diagnostics is a leader in laboratory diagnostic services. What they often don’t know is the depth of the company's experience and capabilities in data, analytics and services across the development continuum. Beyond having over 48 billion clinical lab results in its database, Quest has 2,250 patient service centers, increasingly in retail locations, 20,000 mobile care professionals seeing patients in workplaces and the home. Quest provides services to half the country’s hospitals and physicians roughly a third of the adult U.S. population every year. The Clinical Insights portfolio started in 2015 with dialogue between Quest data scientists and medical directors with researchers in pharma who were trying to understand large patterns in disease progression, diagnosis and treatment. Those dialogues, which continue to this day, produce rich insights and customized at-scale data sets and analysis used for research and the planning of new therapeutic launches.
Op-ed: Is blockchain the technology that’s going to fix healthcare’s many problems? Potentially. But not now. Not even close. Before we can fix healthcare with blockchain, we need to break down the barriers that are preventing blockchain from fixing healthcare. The Synaptic Health Alliance pilot has been a cue about blockchain’s future in healthcare. Led by healthcare giants Aetna, Ascension, Humana, MultiPlan, Optum, UnitedHealthcare, and Quest Diagnostics, the program plans to use blockchain to reduce administrative costs and improve data quality. Early this year, other big-time players — Aetna, Anthem, Health Care Service Corporation (HCSC), PNC Bank, and IBM — announced a new collaborative that will leverage blockchain technology to enhance interoperability and transparency in healthcare. Many smaller partnerships continue to follow suit. However, it doesn't pay to be a guinea pig.
Hc1's software employs machine learning to prevent health systems from ordering too many or too few tests, a mistake that can lead to missed diagnoses and costly procedures.
According to a new analysis by Quest Diagnostics, one-third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018, with marijuana as the most commonly detected drug. The Quest Diagnostics Drug Testing Index is an analysis of more than 14 million urine drug tests of the general U.S. workforce in 17 different sectors.
Quest Diagnostics, through its Cleveland HeartLab subsidiary, has entered into an agreement to purchase for $8.5 million certain assets of bankrupt testing firm True Health Diagnostics.
Michigan is preparing to usher in a new era with legal recreational marijuana sales in 2020, but the state's largest employers say their pre-employment drug screenings that include cannabis will not change. The state's residents already are failing pre-employment drug screening tests at a rate higher than elsewhere in the nation. According to Quest Diagnostics data, the numbers of people who didn't pass pre-employment drug screenings and likely lost potential job opportunities has increased by 31% from 2014 to 2018, and jumped more than 20% between 2017 and 2018, alone. A Quest Diagnostics scientist said the numbers suggest a spike in marijuana use.
Americans largely don't trust the healthcare system to secure their data, and one doesn't have to dig hard to find out why. In 2018, the healthcare sector retained the dubious honor of being the industry with the most data breaches, and less than a quarter of the country trusts health systems to protect their information, according to an August survey by the Harvard T.H. Chain School of Public Health. HHS first began requiring healthcare providers and their business associates to publicly disclose data breaches involving 500 people or more roughly a decade ago. Last year, nearly 300 breaches exposed the records of 11.5 million patients, and one single cybersecurity breach this year hitting the billing collection vendor for lab giants Quest Diagnostics and LabCorp affected the data of nearly 20 million patients.
Laboratory testing is one of the most commonly performed medical activities with, according to the American Clinical Laboratory Association, some 7 billion tests ordered each year.[CR-LF][CR-LF]A substantial number of those tests are likely unnecessary, however. A 2013 meta-analysis published in Plos One, for instance, found that roughly 21 percent of lab test orders represented over-utilization, meaning they didn't add information that was useful to patient careAt the same time, the study put the test underutilization rate at almost 45 percent, indicating that in a substantial proportion of cases, potentially useful tests are never used.[CR-LF][CR-LF]Also last week, Quest Diagnostics announced it had developed in collaboration with bioinformatics firm Hc1 a test utilization optimization system using Hc1's machine learning technology.[CR-LF][CR-LF]Called Quest Lab Stewardship, the product is part of Quest's broader move into providing lab management services for hospitals and health systems.[CR-LF][CR-LF]The system uses guidelines developed by the ABIM Foundation's Choosing Wisely initiative to assess the appropriateness of test orders combined with Hc1's data analysis and integration capabilities to help hospital systems make more effective use of that appropriateness data.
A truck driver who says he took CBD oil for injuries to his hip and back that he suffered in a vehicle accident is suing the company that produced the product, alleging mislabeling.[CR-LF][CR-LF]The lawsuit says that the label stated the product contained no THC, or tetrahydrocannabinol, the compound in marijuana that produces a high. But following a random drug screening, Douglas Horn, of New York, was told by his employer that he tested positive for THC, his lawsuit states.[CR-LF][CR-LF]Employees subject to random drug tests need to be especially careful, said Barry Sample, director of science and technology solutions for Quest Diagnostics, a global diagnostic test and information network.
The National Business Group on Health presented 50 employers with 2019 Best Employers: Excellence in Health & Well-Being awards at its Workforce Strategy 2019 Conference in San Diego this week.[CR-LF][CR-LF]Now in its 15th year, the Best Employers: Excellence in Health & Well-Being awards recognize employers with exceptional commitment to improving their employees’ overall well-being, productivity and quality of life. The awards program incorporates a wide range of well-being contributors including financial security, mental and physical health, social connectedness and community involvement. Quest Diagnostics is listed as a Gold member.
The rate of newly diagnosed acute and chronic hepatitis B virus infections in women of childbearing age has significantly increased in some Appalachian states, despite overall national rates that have declined or remained stable.[CR-LF][CR-LF]Researchers suggested that injection drug use and waning HBV vaccine effectiveness may be contributing to this trend. “Women of childbearing age represent a priority group for HBV viral elimination efforts due to the risk of mother-to-child transmission of HBV,” Harvey W. Kaufman, MD, MBA, FCAP, senior medical director of medical informatics at Quest Diagnostics, told Infectious Disease News. “Higher rates of acute and chronic HBV among women of childbearing age may increase the rates of HBV infection among infants.”
Quest Diagnostics confirmed it has been cleared in US District Court for the Central District of California Western Division of misappropriating trade secrets from Cedars-Sinai Medical Center in developing a serological test for irritable bowel syndrome.[CR-LF][CR-LF]A jury last week determined that Quest did not steal trade secrets from Cedars-Sinai or breach its contract with the hospital when it developed an IBS test similar to one developed by Cedars-Sinai researchers.
Quest Diagnostics announced today that Manuel O. Méndez has been named Senior Vice President and Chief Commercial Officer effective October 7, 2019.
Positive DOT drug tests will be tracked in the new Drug & Alcohol Clearinghouse database.[CR-LF][CR-LF]Photo courtesy Quest Diagnostics.The federal Drug and Alcohol Clearinghouse is finally rolling out in January 2020. This electronic database that will track commercial driver’s license holders who have tested positive for prohibited drug or alcohol use, as well as refusals to take required drug tests, and other drug and alcohol violations. In addition, when a driver who has been found to be in violation completes the required return-to-duty process, this information will also be recorded in the clearinghouse.[CR-LF][CR-LF]The clearinghouse has long been sought as a way to keep commercial drivers who have violated federal drug and alcohol rules from lying about those results and simply getting a job with another motor carrier.
Hospitals frequently license the research and development from their physicians to generate what can be substantial revenue.[CR-LF][CR-LF]Indeed, intellectual property is the bread and butter investment for many academic and nonprofit health systems, helping to bring in some return while allowing physicians, who often develop those innovations themselves, to retain some benefit. Earlier this year, Mayo Clinic said it has generated $600 million in revenue from licensing its IP since 1986.[CR-LF][CR-LF]The dispute between Cedars-Sinai and Quest Diagnostics involves a noninvasive blood test to detect IBS developed by Cedars-Sinai doctor Mark Pimentel.
Quest Diagnostics, the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, unveiled Quest Lab Stewardship powered by hc1, an innovative new service that employs machine learning to harmonise laboratory testing across health systems in order to help optimise laboratory test utilisation.[CR-LF][CR-LF]Quest Lab Stewardship is the result of a strategic collaboration between Quest and hc1 focused on improving costs and clinical impact of lab testing, in- and out- of hospital settings.
Delaware Health Information Network and Quest Diagnostics have been working together for some time, and the network now has extended Quest’s participation as a data provider in Delaware, submitting lab results and clinical data to DHIN. With the new agreement, Quest results will be available to healthcare practitioners statewide through DHIN delivery channels and the Community Health Record’s searchable patient catalog, with the goal to give doctors more actionable information to improve outcomes. Formed in 2007, the Delaware network now offers nearly 20 services.
Quest Diagnostics and hc1 developed a new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization. [CR-LF][CR-LF] Editor's Note: This article originally appeared on Quest Diagnostic's website. [CR-LF][CR-LF]Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™ powered by hc1®, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization.*
Quest Diagnostics and Hc1 are collaborating on a service called Quest Lab Stewardship, which will use Hc1's machine learning technology to help optimize laboratory test use. The technology will collect and analyze laboratory data to improve management of test usage and identify inappropriate or inefficient testing.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™ powered by hc1®, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization.*
Delaware Health Information Network and Quest Diagnostics have been working together for some time, and the network now has extended Quest’s participation as a data provider in Delaware, submitting lab results and clinical data to DHIN. With the new agreement, Quest results will be available to healthcare practitioners statewide through DHIN delivery channels and the Community Health Record’s searchable patient catalog, with the goal to give doctors more actionable information to improve outcomes. Formed in 2007, the Delaware network now offers nearly 20 services.